11/14
06:30 pm
pasg
Passage Bio, Inc. (NASDAQ: PASG) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
High
Report
Passage Bio, Inc. (NASDAQ: PASG) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
11/14
05:50 pm
pasg
Rating for PASG
High
Report
Rating for PASG
11/14
11:11 am
pasg
Rating for PASG
Low
Report
Rating for PASG
9/3
09:01 am
pasg
Passage Bio, Inc. (NASDAQ: PASG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
High
Report
Passage Bio, Inc. (NASDAQ: PASG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
9/3
09:01 am
pasg
Passage Bio, Inc. (NASDAQ: PASG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
High
Report
Passage Bio, Inc. (NASDAQ: PASG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
9/3
08:06 am
pasg
Rating for PASG
Medium
Report
Rating for PASG
9/3
06:58 am
pasg
Passage Bio initiated with bullish view at Rodman & Renshaw
High
Report
Passage Bio initiated with bullish view at Rodman & Renshaw
9/3
06:58 am
pasg
Passage Bio initiated with bullish view at Rodman & Renshaw
High
Report
Passage Bio initiated with bullish view at Rodman & Renshaw